Literature DB >> 9405752

The role of sphincter of Oddi manometry in the diagnosis and therapy of pancreatic disease.

W H Kuo1, P J Pasricha, A N Kalloo.   

Abstract

Endoscopic manometry of the sphincter of Oddi (SO) is now an accepted technique in the diagnosis and therapy of biliary disease. Its role in the evaluation of pancreatic sphincter function for pancreatic diseases, however, is evolving. There are now preliminary data to suggest that pancreatic SO manometry may identify a subgroup of patients with pancreatic sphincter dysfunction that may benefit from endoscopic therapy. Further prospective clinical trials are sorely needed to evaluate the response of endoscopic therapy based on pancreatic SO basal pressure or pancreatic ductal pressure.

Entities:  

Mesh:

Year:  1998        PMID: 9405752

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN: 1052-5157


  6 in total

Review 1.  Endoscopic retrograde cholangiopancreatography in chronic pancreatitis.

Authors:  Peter J Bolan; Aaron S Fink
Journal:  World J Surg       Date:  2003-10-16       Impact factor: 3.352

2.  Recurrent Acute Pancreatitis.

Authors:  Lehel Somogyi; Stephen P. Martin; Charles D. Ulrich
Journal:  Curr Treat Options Gastroenterol       Date:  2001-10

Review 3.  Endoscopic retrograde cholangiopancreatography in the diagnosis and management of pancreatic diseases.

Authors:  R J Shah; S P Martin
Journal:  Curr Gastroenterol Rep       Date:  2000-04

Review 4.  Clinical aspects of sphincter of Oddi function and dysfunction.

Authors:  J Toouli; A Craig
Journal:  Curr Gastroenterol Rep       Date:  1999-04

5.  Effect of somatostatin on the sphincter of Oddi in patients with acute non-biliary pancreatitis.

Authors:  K H Lai; G H Lo; J S Cheng; M T Fu; E M Wang; H H Chan; Y Y Wang; P I Hsu; C K Lin
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

Review 6.  Review of idiopathic pancreatitis.

Authors:  Jason Kihyuk Lee; Robert Enns
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.